ACHFF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Arch Biopartners (ACHFF) Ownership - Who owns Arch Biopartners?

Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

545 King Street West

Phone

+1 647 428-7031

Employees

N/A

Web

https://www.archbiopartners.com

Details

Group

Domestic Stock Funds

Fundamentals

ACHFF

Capitalization

84.9M

P/E Ratio

N/A

Risk (Beta)

1.67

Dividend Yield

N/A

Total Cash

54.8K

Total Cash/Share

0.00

Total Debt

2.83M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

-4.26M

P/B Ratio

N/A

Cash Flow

N/A

Earnings

-0.05

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

17.9M

Current Ratio

0.11

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-3.18M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

N/A

Shares Outstanding - Current

65.9M

Total Liabilities

4.79M

Total Volume MTD

N/A

Value

-1

Gain YTD

-5.926

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology